| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp | EVP of R&D & CTO | Common Stock | 11,980 | $327,173 | $27.31 | 15 Oct 2025 | Direct |
| QuidelOrtho Corp | EVP of R&D & CTO | Restricted Stock Units | 37,314 | $304,261 | $41.42 | 15 Oct 2025 | Direct |
| QuidelOrtho Corp | EVP of R&D & CTO | Non-Qualified Stock Options | 7,347 | 29 Jan 2025 | Direct | ||
| QuidelOrtho Corp | EVP of R&D & CTO | No securities beneficially owned | 0 | 07 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QDEL | QuidelOrtho Corp | 15 Oct 2025 | 3 | -$182,322 | 4 | EVP of R&D & CTO | 17 Oct 2025, 16:16 |
| QDEL | QuidelOrtho Corp | 29 Jan 2025 | 2 | $0 | 4 | EVP of R&D & CTO | 31 Jan 2025, 18:29 |
| QDEL | QuidelOrtho Corp | 07 Oct 2024 | 0 | $0 | 3 | EVP of R&D & CTO | 17 Oct 2024, 16:47 |